CHRISTY GEORGESON: Open Payments
NPI 1912315557 · STATESVILLE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$768 in 46 payments from 12 companies in 2025. Trend: 2023 $647 · 2024 $624 · 2025 $768
Food & beverage: $768
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 19 | $270 |
| ABBVIE INC. | 10 | $158 |
| PFIZER INC. | 5 | $115 |
| AstraZeneca Pharmaceuticals LP | 3 | $53 |
| Amgen Inc. | 2 | $35 |
| Dexcom, Inc. | 1 | $29 |
| Verona Pharma, Inc. | 1 | $24 |
| Abbott Laboratories | 1 | $21 |
| GlaxoSmithKline, LLC. | 1 | $19 |
| E.R. Squibb & Sons, L.L.C. | 1 | $16 |
Products named: Wegovy, ELIQUIS, UBRELVY, Rybelsus, AIRSUPRA, QULIPTA, NURTEC ODT, VRAYLAR.
Industry payments across NC — which companies pay providers there.
